Pharma is a ‘mixed bag’ when providing drug access to low- and middle-income countries, analysis finds Access plans now cover 69% of late-stage pipeline candidates compared with 18% in 2018

https://www.statnews.com/pharmalot/2026/11/10/access-to-key-drugs-mixed-in-poor-countries-cancer-diabetes/ By Ed SilvermanNov. 10, 2026 Pharmalot Columnist, Senior Writer